Citadel Advisors’s Biote Corp. Warrant BTMDW Stock Holding History

Citadel Advisors’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,108	Closed	-$17.9K	–	15622
2023 Q2	$17.9K	Buy	11,108 +8	+0.1%	+$8	﹤0.01%	12833
2023 Q1	$4.66K	Buy	+11,100	New	+$4.03K	﹤0.01%	13936
2022 Q1	–	Sell	-74,390	Closed	-$54K	–	14987
2021 Q4	$54K	Buy	74,390 +53,881	+263%	+$43.4K	﹤0.01%	13210
2021 Q3	$16K	Buy	+20,509	New	+$18.3K	﹤0.01%	13663

Citadel Advisors's BTMDW Position: Q3 2023 in Review

Citadel Advisors sold out of Biote Corp. Warrant (BTMDW) in Q3 2023, closing a stake of 11,108 shares — an estimated $17.9K sold.

Citadel Advisors first reported a position in BTMDW in Q3 2021 and held it in 4 quarters. The position peaked at $54K in Q4 2021. 0 funds tracked by Wall St. Rank hold BTMDW as of Q3 2023.

Citadel Advisors reported no remaining Biote Corp. Warrant position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 11,108 Biote Corp. Warrant shares in Q3 2023, an estimated $17.9K.
Citadel Advisors first reported a position in Biote Corp. Warrant in Q3 2021 and held it in 4 quarters.
Citadel Advisors's Biote Corp. Warrant position peaked at $54K in Q4 2021.
0 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.